ED
VRSN icon

Exane Derivatives’s VeriSign VRSN Stock Holding History

Exane Derivatives’s Portfolio VRSN Stock Details VRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-136
Closed -$10.6K – 686
2016
Q3 		$10.6K Hold
136
– – ﹤0.01% 396
2016
Q2 		$11.8K Buy
+136
New +$11.7K ﹤0.01% 360
2015
Q2 		– Sell
-11
Closed -$737 – 560
2015
Q1 		$737 Sell
11
-216,191
-100% -$13.1M ﹤0.01% 452
2014
Q4 		$12.3M Buy
+216,202
New +$12.5M 1.71% 31

Other funds holding VRSN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Exane Derivatives's VRSN Position: Q4 2016 in Review

Exane Derivatives sold out of VeriSign (VRSN) in Q4 2016, closing a stake of 136 shares — an estimated $10.6K sold.

Exane Derivatives first reported a position in VRSN in Q4 2014 and held it in 4 quarters. The position peaked at $12.3M in Q4 2014. 416 funds tracked by Wall St. Rank hold VRSN as of Q4 2016.

  • Exane Derivatives reported no remaining VeriSign position as of Q4 2016 after selling out during the quarter.
  • Exane Derivatives sold 136 VeriSign shares in Q4 2016, an estimated $10.6K.
  • Exane Derivatives first reported a position in VeriSign in Q4 2014 and held it in 4 quarters.
  • Exane Derivatives's VeriSign position peaked at $12.3M in Q4 2014.
  • 416 funds tracked by Wall St. Rank held VeriSign as of Q4 2016.

Based on Exane Derivatives's 13F filing for Q4 2016, filed 27 Jan 2017.